ropivacaine hydrochloride

Product NDC: 25021-671
Requested package NDC: 25021-671-87
11-digit product format: 250210671
Labeler code: 25021
Product ID: 25021-671_22d83514-0f7b-4671-ae6a-7ca47449c184
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ropivacaine hydrochloride
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL; INFILTRATION
Labeler: Sagent Pharmaceuticals
Application: ANDA206166
Marketing category: ANDA
Marketing start: 2020-01-01
Substance: ROPIVACAINE HYDROCHLORIDE
Active strength: 2 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A206166-001	ROPIVACAINE HYDROCHLORIDE	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11
A206166-002	ROPIVACAINE HYDROCHLORIDE	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11
A206166-003	ROPIVACAINE HYDROCHLORIDE	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11
A206166-004	ROPIVACAINE HYDROCHLORIDE	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A206166-001	AP
A206166-002	AP
A206166-003	AP
A206166-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-001	ROPIVACAINE HYDROCHLORIDE	200MG/100ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-002	ROPIVACAINE HYDROCHLORIDE	400MG/200ML (2MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-003	ROPIVACAINE HYDROCHLORIDE	500MG/100ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-004	ROPIVACAINE HYDROCHLORIDE	1GM/200ML (5MG/ML)	SOLUTION / INJECTION	AP	2018-06-11	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A206166-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-002	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-003	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206166-004	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A206166-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206166-004	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206166-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206166-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206166-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206166-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206166-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206166-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206166-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206166-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206166-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206166-004	AP	1	`5bbf6a4d5a75…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ropivacaine hydrochloride
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ROPIVACAINE HYDROCHLORIDE	2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
V910P86109	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1734347	Internal RxNorm lookup
1734355	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9572b3de-684c-4028-a577-5aa69ba6b02d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
387afa15-cb51-403a-b2e2-1c9d201e07dc	Product name	9	20230426

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
25021-671-82	ropivacaine hydrochloride	100 mL in 1 BAG	INJECTION, SOLUTION	100	11
25021-671-82	ropivacaine hydrochloride	10 in 1 CARTON	INJECTION, SOLUTION	10	11
25021-671-87	ropivacaine hydrochloride	200 mL in 1 BAG	INJECTION, SOLUTION	200	11
25021-671-87	ropivacaine hydrochloride	10 in 1 CARTON	INJECTION, SOLUTION	10	11
25021-671-66	ropivacaine hydrochloride	100 mL in 1 BAG	INJECTION, SOLUTION	100	5
25021-671-66	ropivacaine hydrochloride	10 in 1 CARTON	INJECTION, SOLUTION	10	5
25021-671-67	ropivacaine hydrochloride	10 in 1 CARTON	INJECTION, SOLUTION	10	5
25021-671-67	ropivacaine hydrochloride	200 mL in 1 BAG	INJECTION, SOLUTION	200	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
25021-671-20	ML - Milliliter	25021-671	a2b2c0f7-48eb-4b53-ac8f-51729b1edf0d	1	2014-10-03
25021-671-66	ML - Milliliter	25021-671	c1f1f50b-ed16-42f2-b8d8-4668ea825acf	1	2020-05-08
25021-671-67	ML - Milliliter	25021-671	ab43db9e-27e3-459e-a5bb-2cd4bf24495c	1	2020-05-08
25021-671-82	ML - Milliliter	25021-671	04e5efef-fcd2-4ca4-bfd8-dbecdf77def8	1	2019-02-13
25021-671-87	ML - Milliliter	25021-671	93ffe764-6b68-4fd1-af54-eeba6bb40824	1	2019-02-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
25021-671	ROPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]	10	Current NDC, Legacy NDC, 4 package rows	20240328_8c5c762f-d266-4b1a-809e-f11bfc89bc2d.zip
25021-671	ROPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]	4	Current NDC, Legacy NDC, 4 package rows	20240328_9572b3de-684c-4028-a577-5aa69ba6b02d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ropivacaine hydrochloride	ROPIVACAINE HYDROCHLORIDE	Sagent Pharmaceuticals	9572b3de-684c-4028-a577-5aa69ba6b02d	2025-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206166 application number: ANDA206166 ndc (product): 25021-671
ropivacaine hydrochloride	ROPIVACAINE HYDROCHLORIDE	Sagent Pharmaceuticals	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	2025-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206166 application number: ANDA206166 ndc (package): 25021-671-87 ndc (product): 25021-671 ndc11 (package): 25021067187

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V910P86109	ROPIVACAINE HYDROCHLORIDE	132112-35-7	ROPIVACAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1734347	ROPivacaine HCl 0.2 % in 100 ML Injection	PSN	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734355	ROPivacaine HCl 0.2 % in 200 ML Injection	PSN	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734479	ROPivacaine HCl 0.5 % in 100 ML Injection	PSN	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734481	ROPivacaine HCl 0.5 % in 200 ML Injection	PSN	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734347	100 ML ropivacaine hydrochloride 2 MG/ML Injection	SCD	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734479	100 ML ropivacaine hydrochloride 5 MG/ML Injection	SCD	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734355	200 ML ropivacaine hydrochloride 2 MG/ML Injection	SCD	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734481	200 ML ropivacaine hydrochloride 5 MG/ML Injection	SCD	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734347	ropivacaine HCl 0.2 % per 100 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734355	ropivacaine HCl 0.2 % per 200 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734479	ropivacaine HCl 0.5 % per 100 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734481	ropivacaine HCl 0.5 % per 200 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734481	ropivacaine HCl 1000 MG per 200 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734347	ropivacaine HCl 200 MG per 100 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734355	ropivacaine HCl 400 MG per 200 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734479	ropivacaine HCl 500 MG per 100 ML Injection	SY	8c5c762f-d266-4b1a-809e-f11bfc89bc2d	11
1734347	ROPivacaine HCl 0.2 % in 100 ML Injection	PSN	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734355	ROPivacaine HCl 0.2 % in 200 ML Injection	PSN	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734347	100 ML ropivacaine hydrochloride 2 MG/ML Injection	SCD	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734355	200 ML ropivacaine hydrochloride 2 MG/ML Injection	SCD	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734347	ropivacaine HCl 0.2 % per 100 ML Injection	SY	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734355	ropivacaine HCl 0.2 % per 200 ML Injection	SY	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734347	ropivacaine HCl 200 MG per 100 ML Injection	SY	9572b3de-684c-4028-a577-5aa69ba6b02d	5
1734355	ropivacaine HCl 400 MG per 200 ML Injection	SY	9572b3de-684c-4028-a577-5aa69ba6b02d	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
25021-671-87	25021067187	10 BAG in 1 CARTON (25021-671-87) / 200 mL in 1 BAG	10 bag	2018-12-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ropivacaine hydrochloride	Sagent Pharmaceuticals	2025-08-06	HUMAN PRESCRIPTION DRUG LABEL	11
ropivacaine hydrochloride	Sagent Pharmaceuticals	2025-08-06	HUMAN PRESCRIPTION DRUG LABEL	5